Delivery Order SPE2DB22D3004-SPE2DB25FRE60
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $44,036.16 for the supply of XEOMIN 100 unit vials. The contract is an open competition, with no set-aside requirements. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,704.88 firm fixed-price delivery order is for the supply of 4,567,553,409 units of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 1, 2025 and was awarded on March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $13,968.50 and a completion date of July 16, 2025. The contract is for the supply of XEOMIN 100 unit vials and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award is for the delivery of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,572.72 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, with a potential value of $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XEOMIN 100 unit vials. The $5,587.40 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This federal contract award is for the delivery of XEOMIN 100 unit vials, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed price Delivery Order with a ceiling value of $13,106 and an ultimate completion date of November 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This federal contract award, valued at $1,179.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,738,226 units of XEOMIN 50 unit vials. The contract is a Firm Fixed Price Delivery Order that runs through January 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,106.25 firm fixed-price delivery order is for the supply of XEOMIN 200 unit vials, with a period of performance through June 11, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-unit vials of the pharmaceutical product XEOMIN. The $16,762.20 fixed-price contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 28, 2025. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,727.50 firm fixed-price delivery order is for the supply of XEOMIN 200 unit vials. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRE60Delivery Order
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The $46,934.16 fixed-price contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period ending on July 17, 2025. The award is not set aside and indicates open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.9k | 6/25/25 |